MA38310A1 - Combination drug comprising phenylephrine and paracetamol - Google Patents
Combination drug comprising phenylephrine and paracetamolInfo
- Publication number
- MA38310A1 MA38310A1 MA38310A MA38310A MA38310A1 MA 38310 A1 MA38310 A1 MA 38310A1 MA 38310 A MA38310 A MA 38310A MA 38310 A MA38310 A MA 38310A MA 38310 A1 MA38310 A1 MA 38310A1
- Authority
- MA
- Morocco
- Prior art keywords
- phenylephrine
- paracetamol
- pharmaceutically acceptable
- alternative form
- combination
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne l'utilisation d'hydrochlorure de phényléphrine (ou une forme alternative pharmaceutiquement acceptable de phényléphrine) et de paracétamol dans la production d'une combinaison médicamenteuse destinée à traiter la congestion des muqueuses des voies respiratoires supérieures, le procédé consistant à combiner lesdites substances avec des excipients, et caractérisé en ce que le médicament comprend l'hydrochlorure de phényléphrine (ou la forme alternative pharmaceutiquement acceptable de phényléphrine) et le paracétamol dans des proportions appropriées pour l'administrer à un adulte, ledit médicament étant destiné à un adulte, qui sont : a) de 4 mg à 7,5 mg d'hydrochlorure de phényléphrine, (ou une quantité équivalente d'une forme alternative pharmaceutiquement acceptable de phényléphrine) en combinaison avec une quantité de 950 mg à 1000 mg de paracétamol ; ou b) de 5 mg à 7,5 mg d'hydrochlorure de phényléphrine (ou une quantité équivalente d'une forme alternative pharmaceutiquement acceptable de phényléphrine) en combinaison avec une quantité de 600 mg à 700 mg de paracétamol ; ou c) de 6 mg à 8 mg d'hydrochlorure de phényléphrine (ou une quantité équivalente d'une forme alternative pharmaceutiquement acceptable de phényléphrine) en combinaison avec une quantité de 500 mg à 550 mg de paracétamol.The invention relates to the use of phenylephrine hydrochloride (or a pharmaceutically acceptable alternative form of phenylephrine) and paracetamol in the production of a medicinal combination for treating congestion of the mucous membranes of the upper respiratory tract, the method of combining said substances with excipients, and characterized in that the medicament comprises phenylephrine hydrochloride (or the pharmaceutically acceptable alternative form of phenylephrine) and paracetamol in proportions suitable for administration to an adult, said medicament being for use in a adult, which are: a) from 4 mg to 7.5 mg phenylephrine hydrochloride, (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine) in combination with an amount of 950 mg to 1000 mg paracetamol; or b) from 5 mg to 7.5 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine) in combination with an amount of 600 mg to 700 mg paracetamol; or c) from 6 mg to 8 mg of phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine) in combination with an amount of 500 mg to 550 mg of paracetamol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ60665913 | 2013-02-04 | ||
| PCT/NZ2014/000001 WO2014120021A1 (en) | 2013-02-04 | 2014-01-07 | A combination medicament comprising phenylephrine and paracetamol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38310A1 true MA38310A1 (en) | 2016-12-30 |
| MA38310B2 MA38310B2 (en) | 2019-11-29 |
Family
ID=56119021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38310A MA38310B2 (en) | 2013-02-04 | 2014-01-07 | Combination drug comprising phenylephrine and paracetamol |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR095149A1 (en) |
| MA (1) | MA38310B2 (en) |
-
2014
- 2014-01-07 MA MA38310A patent/MA38310B2/en unknown
- 2014-02-04 AR ARP140100373A patent/AR095149A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA38310B2 (en) | 2019-11-29 |
| AR095149A1 (en) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201892657A1 (en) | SPYROLACTAM MODULATORS OF THE NMDA-RECEPTOR AND THEIR APPLICATION | |
| EA201691454A1 (en) | COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| EA201792592A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN | |
| EA201990424A1 (en) | SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION | |
| EA201990428A1 (en) | SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION | |
| EA201792345A1 (en) | PROTECTED FROM APPLICATION NOT FOR THE PURPOSE OF THE MEDICINE FORM WITH IMMEDIATE DELIVERY AND RESISTANCE TO EXTRACTION BY SOLVENTS | |
| EA201990425A1 (en) | SPIRO-LACTAM AND BIS-SPIRO-LACTAM MODULATORS OF THE NMDA RECEPTOR AND THEIR APPLICATION | |
| MX2010002735A (en) | Titration package for neramexane and its use in the treatment of an inner ear disorder. | |
| EA201792591A1 (en) | PHARMACEUTICAL PREPARATIONS | |
| BR112018015367A2 (en) | nanofiber oromucosal carriers for therapeutic treatment | |
| MX2022015629A (en) | Use of vibegron to treat overactive bladder. | |
| EA201591188A1 (en) | DELIVERY OF GLETIRAMER ACETATE THROUGH THE SLIGHTY SHELL | |
| EA202090542A1 (en) | HIGHLY CONCENTRATED MEDICINAL FORMS OF Pridopidine | |
| CO2019003808A2 (en) | Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof | |
| MX2016010892A (en) | Agent for improving or preventing progression of chronic kidney disease. | |
| EA202191063A1 (en) | NEW DOSE FORM | |
| MX2021001845A (en) | A combination medicament comprising phenylephrine and paracetamol. | |
| MA31227B1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING PHLOROGLUCINOL AND PARACETAMOL. | |
| MA38310A1 (en) | Combination drug comprising phenylephrine and paracetamol | |
| MX2018013475A (en) | Carboxylic acid for treating/preventing nasal congestion. | |
| PH12018500889A1 (en) | Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestine | |
| EA201991007A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS BASED ON LURAZIDONE HYDROCHLORIDE FOR ORAL USE | |
| PH12019501607A1 (en) | Tapentadol nasal composition | |
| EA201992690A1 (en) | APPLICATION OF VIBEGRON FOR TREATMENT OF A HYPERACTIVE BLADDER |